Drug recall · September 8, 2021
Lidocaine Ointment USP recall
Why: Failed Viscosity Specifications: lot does not meet specification for Viscosity, which was determined through routine testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Lidocaine Ointment USP, 5% Rx Only, Net Wt 35.44 g(1 1/4 oz)packaged in a laminat tube, Teligent Pharma, Inc. Buena, New Jersey 08310, NDC 52565-008-14.
- Lots / codes
Lot #: 15378, Exp 3/2023; 14418 EXP 10/2021
- Quantity
- 114,456 tubes
- Company
- Teligent Pharma, Inc., Buena, NJ
- Distribution
- Distributed Nationwide in the USA
- Initiated
- July 29, 2021 · Voluntary: Firm initiated
- Classified
- August 31, 2021
- Reported
- September 8, 2021
- Ended
- August 15, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.